Johannes Pfeilschifter

Summary

Country: Germany

Publications

  1. ncbi Changes in proinflammatory cytokine activity after menopause
    Johannes Pfeilschifter
    Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D 44789 Bochum, Germany
    Endocr Rev 23:90-119. 2002
  2. ncbi [Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy]
    Matthias Imohl
    Institut fur Klinische Chemie, Transfusions und Laboratoriumsmedizin, Universitatsklinik der Ruhr Universitat Bochum
    Med Klin (Munich) 97:747-53. 2002
  3. ncbi [Osteoporosis and falls in Germany: health care for the elderly with an increased risk for fractures]
    Jochen Schumacher
    Klinik für Altersmedizin und Frührehabilitation, Marienhospital Herne Universitätsklinik der Ruhr Universität Bochum
    Z Arztl Fortbild Qualitatssich 101:593-7. 2007
  4. ncbi Role of cytokines in postmenopausal bone loss
    Johannes Pfeilschifter
    Berufsgenossenschaftliche Kliniken Bergmannsheil, Department of Medicine, University of Bochum, Burkle de la Camp Platz 1, D 44789 Bochum, Germany
    Curr Osteoporos Rep 1:53-8. 2003
  5. ncbi Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study)
    Heinrich Schmidt-Gayk
    Department of Endocrinology and Oncology, Limbach Laboratory, Im Breitspiel 15, 69126 Heidelberg, Germany
    Clin Chem Lab Med 42:90-5. 2004
  6. ncbi Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis
    Hans-Peter Kruse
    Curr Med Res Opin 20:1821-2; author reply 1822-4. 2004
  7. ncbi Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers
    Claudia Langenberg
    Department of Family and Preventive Medicine, School of Medicine, University of California-San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0607, USA
    Diabetes Care 29:1363-9. 2006

Collaborators

Detail Information

Publications7

  1. ncbi Changes in proinflammatory cytokine activity after menopause
    Johannes Pfeilschifter
    Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D 44789 Bochum, Germany
    Endocr Rev 23:90-119. 2002
    ..Better knowledge of the mechanisms and the time course of these interactions may open new avenues for the prevention and treatment of some of the most prevalent and important disorders in postmenopausal women...
  2. ncbi [Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy]
    Matthias Imohl
    Institut fur Klinische Chemie, Transfusions und Laboratoriumsmedizin, Universitatsklinik der Ruhr Universitat Bochum
    Med Klin (Munich) 97:747-53. 2002
    ....
  3. ncbi [Osteoporosis and falls in Germany: health care for the elderly with an increased risk for fractures]
    Jochen Schumacher
    Klinik für Altersmedizin und Frührehabilitation, Marienhospital Herne Universitätsklinik der Ruhr Universität Bochum
    Z Arztl Fortbild Qualitatssich 101:593-7. 2007
    ..In these sectors a deficiency in the delivery of care is apparent. Standardized evaluations of the implementation of guidelines are needed to assess deficiencies and reveal options for improving quality of care in the future...
  4. ncbi Role of cytokines in postmenopausal bone loss
    Johannes Pfeilschifter
    Berufsgenossenschaftliche Kliniken Bergmannsheil, Department of Medicine, University of Bochum, Burkle de la Camp Platz 1, D 44789 Bochum, Germany
    Curr Osteoporos Rep 1:53-8. 2003
    ..This article summarizes our current knowledge of these interactions and discusses the possible implications with respect to the prevention and treatment of postmenopausal osteoporosis...
  5. ncbi Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study)
    Heinrich Schmidt-Gayk
    Department of Endocrinology and Oncology, Limbach Laboratory, Im Breitspiel 15, 69126 Heidelberg, Germany
    Clin Chem Lab Med 42:90-5. 2004
    ..This has been shown in several external quality assessment schemes (EQAS)...
  6. ncbi Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis
    Hans-Peter Kruse
    Curr Med Res Opin 20:1821-2; author reply 1822-4. 2004
  7. ncbi Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers
    Claudia Langenberg
    Department of Family and Preventive Medicine, School of Medicine, University of California-San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0607, USA
    Diabetes Care 29:1363-9. 2006
    ..CONCLUSIONS: Adiposity-signaling hormones and inflammatory markers explain little to some of the association between the metabolic syndrome and CHD mortality. IL-6 levels predict CHD mortality independently of CRP...